The Chosun Ilbo on MSN

Samsung Invests in U.S. Gene-Editing Firm Averr BioTechnology

Samsung is proceeding with an investment in Averr BioTechnology (Averr Bio), a U.S.-based biotech company specializing in ...
STAT

With $1.3 billion in hand, VC firm Frazier remains bullish on biotech

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.